FDA Import Refusal 112-2192253-9/1/18 — Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc. — FEI 1219205

The FDA refused shipment 112-2192253-9/1/18 from Boehringer Ingelheim Pharmaceuticals, Inc. (United States) on Jul 16, 2006. The refused product falls under Drugs and Biologics — MELOXICAM (ANTI-INFLAMMATORY, PART II). Cited charge: 179 This firm has 5 or more other import refusals on record.

Refusal Details

Date
Jul 16, 2006
Country
United States
Product Category
Drugs and Biologics
Product Code
62YCA07 MELOXICAM (ANTI-INFLAMMATORY, PART II)
Charges
179